https://www.prometrika.com/thought-leadership/regulatory-corner/ Tue, 14 Apr 2026 07:37:25 -0400 60 Tue, 07 Apr 2026 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/substantial-evidence-of-effectiveness-are-we-ready-for-one-pivotal-study/ https://www.prometrika.com/thought-leadership/regulatory-corner/substantial-evidence-of-effectiveness-are-we-ready-for-one-pivotal-study/ Mon, 30 Mar 2026 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/the-perils-and-pitfalls-in-the-development-of-novel-combinations-of-cancer-drugs/ https://www.prometrika.com/thought-leadership/regulatory-corner/the-perils-and-pitfalls-in-the-development-of-novel-combinations-of-cancer-drugs/ Tue, 06 Jan 2026 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/do-no-harm-importance-of-overall-survival-in-randomized-oncology-clinical-trials/ https://www.prometrika.com/thought-leadership/regulatory-corner/do-no-harm-importance-of-overall-survival-in-randomized-oncology-clinical-trials/ Mon, 01 Dec 2025 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/what-is-fdas-authority-to-revoke-an-approval-and-how-does-this-work/ https://www.prometrika.com/thought-leadership/regulatory-corner/what-is-fdas-authority-to-revoke-an-approval-and-how-does-this-work/ Thu, 01 Aug 2024 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/optimizing-dosage-in-oncology-more-may-not-always-be-better/ https://www.prometrika.com/thought-leadership/regulatory-corner/optimizing-dosage-in-oncology-more-may-not-always-be-better/ Sun, 30 Jun 2024 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/fdas-platform-technology-designation-what-is-it-and-how-can-it-help-me/ https://www.prometrika.com/thought-leadership/regulatory-corner/fdas-platform-technology-designation-what-is-it-and-how-can-it-help-me/ Tue, 30 Apr 2024 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/valuable-guidance-in-fdas-considerations-for-the-conduct-of-clinical-trials-during-major-disruptions/ https://www.prometrika.com/thought-leadership/regulatory-corner/valuable-guidance-in-fdas-considerations-for-the-conduct-of-clinical-trials-during-major-disruptions/ Sun, 31 Mar 2024 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/implementing-the-fda-guidance-on-key-information-in-informed-consent/ https://www.prometrika.com/thought-leadership/regulatory-corner/implementing-the-fda-guidance-on-key-information-in-informed-consent/ Thu, 29 Feb 2024 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/benefit-risk-assessments-for-new-drug-and-biological-products-not-just-for-marketing-applications-anymore/ https://www.prometrika.com/thought-leadership/regulatory-corner/benefit-risk-assessments-for-new-drug-and-biological-products-not-just-for-marketing-applications-anymore/ Wed, 31 Jan 2024 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/a-tale-of-two-clinical-programs/ https://www.prometrika.com/thought-leadership/regulatory-corner/a-tale-of-two-clinical-programs/ Tue, 12 Dec 2023 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/the-m11-template-clinical-electronic-structured-harmonised-protocol-cesharp/ https://www.prometrika.com/thought-leadership/regulatory-corner/the-m11-template-clinical-electronic-structured-harmonised-protocol-cesharp/ Thu, 09 Nov 2023 00:00:00 -0500 https://www.prometrika.com/thought-leadership/regulatory-corner/navigating-fdas-guideline-on-the-use-of-real-world-data-and-real-world-evidence-in-support-of-new-indications/ https://www.prometrika.com/thought-leadership/regulatory-corner/navigating-fdas-guideline-on-the-use-of-real-world-data-and-real-world-evidence-in-support-of-new-indications/ Thu, 26 Oct 2023 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/the-pathway-to-approval-for-two-gene-therapy-products/ https://www.prometrika.com/thought-leadership/regulatory-corner/the-pathway-to-approval-for-two-gene-therapy-products/ Tue, 05 Sep 2023 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/harmonizing-investigational-and-post-marketing-safety-reporting/ https://www.prometrika.com/thought-leadership/regulatory-corner/harmonizing-investigational-and-post-marketing-safety-reporting/ Tue, 01 Aug 2023 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/establishing-efficacy-based-on-a-single-arm-trial-sat/ https://www.prometrika.com/thought-leadership/regulatory-corner/establishing-efficacy-based-on-a-single-arm-trial-sat/ Fri, 14 Jul 2023 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/fda-accelerated-approval-of-oncology-therapeutics-guidance/ https://www.prometrika.com/thought-leadership/regulatory-corner/fda-accelerated-approval-of-oncology-therapeutics-guidance/ Thu, 01 Jun 2023 00:00:00 -0400 https://www.prometrika.com/thought-leadership/regulatory-corner/the-role-of-regulatory-affairs-in-drug-development/ https://www.prometrika.com/thought-leadership/regulatory-corner/the-role-of-regulatory-affairs-in-drug-development/